Lovelace Scientific

Lovelace Biomedical is a long-established, not-for-profit preclinical CRO with a strong focus on complex research areas like respiratory diseases, infectious diseases, and gene therapies. Its key differentiators include a flexible, client-centric operational model, a large, high-containment facility with extensive animal housing, and a mission-driven approach free from shareholder pressure. The company leverages a multidisciplinary scientific team and a full suite of GLP-compliant services—from toxicology to bioanalytical chemistry—to support pharmaceutical and biotech partners in drug development.

Integrated preclinical CRO platform with high-containment (ABSL3) facilities, aerosol exposure labs, and full-service capabilities in toxicology, pharmacology, PK/TK, bioanalytical chemistry, and formulation. Supports complex models for respiratory, infectious disease, and gene therapy research.

Competes with large, publicly-traded CROs (e.g., Charles River, Labcorp) and smaller niche preclinical providers. Differentiation is based on specialized high-containment capabilities, a flexible/client-centric service model, and a not-for-profit, science-driven mission.